Vanda Pharmaceuticals Inc. (VNDA) stock
VNDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/3056% below fair value
$3.75−0.06 (-1.57%)
Close on Nov 18, 2026Market cap $226.76MP/E –Yield –
Vanda Pharmaceuticals market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Vanda Pharmaceuticals's market cap was $250.89M on Nov 11, 2026, against $316.75M a year earlier. Over the last 5 years it ranged from $207.11M to $874.07M, with a median of $326.46M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $250.89M | -51.9% |
| 2025 | Dec 31, 2025 | $521.22M | +86.6% |
| 2024 | Dec 31, 2024 | $279.29M | +15.0% |
| 2023 | Dec 29, 2023 | $242.77M | -41.9% |
| 2022 | Dec 30, 2022 | $418.19M | -52.2% |
| 2021 | Dec 31, 2021 | $874.07M | +21.6% |
| 2020 | Dec 31, 2020 | $718.62M | -17.9% |
| 2019 | Dec 31, 2019 | $875.20M | -36.1% |
| 2018 | Dec 31, 2018 | $1.37B | +100.5% |
| 2017 | Dec 29, 2017 | $682.83M | -2.5% |
| 2016 | Dec 30, 2016 | $700.69M | +75.8% |
| 2015 | Dec 31, 2015 | $398.61M | -17.9% |
| 2014 | Dec 31, 2014 | $485.46M | +17.9% |
| 2013 | Dec 31, 2013 | $411.89M | +294.4% |
| 2012 | Dec 31, 2012 | $104.44M | -21.9% |
| 2011 | Dec 30, 2011 | $133.81M | -47.6% |
| 2010 | Dec 31, 2010 | $255.56M | – |
See a number that looks wrong?